Oxford Immunotec Global PLC announced the appointment of Stefan Linn as Chief Operating Officer. Mr. Linn joins Oxford Immunotec with extensive experience building and leading companies through growth strategies, operational improvements, and acquisitions. Most recently, Mr. Linn served as Senior Vice President, Strategy and Commercial Operations, for IMS Health Holdings Inc. In this role, he was responsible for advancing IMS Health’s global growth agenda, including leading strategic planning and commercial operations activities, expansion of the company’s product offering, and the identification and integration of acquisitions. Mr. Linn joined IMS Health from TPG Capital, where he worked with TPG’s healthcare and consumer portfolio companies to drive operating improvements. Prior to joining TPG, Mr. Linn was a Senior Vice President at McKesson Corporation, where he was responsible for marketing strategy, product development and customer programs. During his tenure at McKesson, Mr. Linn also served as President of Health Mart, and oversaw McKesson’s consumer products division, packaging business RxPack, and the McKesson Patient Relationship Solutions division.